I-MAK is a brand initiative dedicated to building a more just and equitable medicines system for all. They challenge systemic injustice and advocate for health equity in drug development and access. Millions of lives are lost due to an unjust system that prevents the most vulnerable from accessing the medicines they need.

I-MAK aims to change this by partnering with organizations committed to systemic change at every level. With almost 20 years of experience, they have successfully litigated and won cases for health justice worldwide. Their work has impacted 70% of countries by working in 49 countries.

I-MAK provides various resources, including an exclusive report series on excessive pharmaceutical patenting, a searchable database on top-selling drugs, and a data summary on patent, pricing, spending, and market data for the top-selling drugs in America. Their team of lawyers, scientists, and global health experts is dedicated to researching, educating, and partnering to create impactful solutions. Join them now and help build a more equitable medicine system for all